An information platform for unlisted & pre-IPO sharesNot a SEBI-recognised stock exchange or trading platformAll prices are indicative
UnlistedZone
HomeResearchRenewbuy Secures $10M Funding Amid Merger with InsuranceDekho: What It Means for India's Insurtech Sector
Research20 Jun 2025

Renewbuy Secures $10M Funding Amid Merger with InsuranceDekho: What It Means for India's Insurtech Sector

Renewbuy Secures $10M Funding Amid Merger with InsuranceDekho: What It Means for India's Insurtech Sector

A) Introduction In a strategic move signaling deep consolidation in India’s insurtech space, Renewbuy has raised $10 million (₹86 crore) in fresh funding from existing investors Apis Partners and 360 One (formerly IIFL Wealth). This bridge round comes at a critical juncture as the company prepares to merge with rival InsuranceDekho, a merger that could reshape the competitive landscape in India's insurance broking sector. B) Funding, Valuation & Merger Status Amount Raised: $10 million (₹86 crore) Investors: Apis Partners (UK), 360 One (IIFL Wealth) Purpose: To support operations and expansion until the merger is finalized Merger Partner: InsuranceDekho (CarDekho-backed) First Reported: October 2024 IRDAI Approval: Pending Valuation Estimate (Combined Entity): $1 billion Renewbuy’s Last Valuation: $524 million (June 2023, per Tracxn) C) Financials & Business Model Revenue (FY24): ₹410 crore Net Loss (FY24): ₹114 crore Business Model: Hybrid distribution with physical agent network Products: Motor, Health, and Life Insurance Target Markets: Strong presence in Tier II and Tier III cities D) Competition & Capital History Competitors: InsuranceDekho – CarDekho-backed, leading digital-first platform PB Partners – Policybazaar's agent-led channel Turtlemint – Backed by Peak XV (formerly Sequoia Capital) Total Funds Raised: $41M+ since inception in 2014 Notable Backers: Apis Partners, 360 One, Dai-ichi Life (Japan) E) Strategic Significance Operational Continuity: The funding ensures that Renewbuy can continue scaling and servicing its network without disruptions while regulatory approvals are awaited. Consolidation Trend: Signals a broader consolidation wave in Indian insurtech, as firms move from growth-at-all-costs to profitability and market share leadership. Market Impact: The merged entity could emerge as India’s largest insurance broker, mounting serious competition for Policybazaar. F) What This Means for Investors For unlisted market investors, this deal highlights: Renewed investor faith in hybrid distribution models M&A potential as a value unlock mechanism Attractive pre-IPO bets in India’s booming insurtech market G) Final Outlook IRDAI approval for the merger is expected in the coming quarters Post-merger integration and potential IPO discussions may follow in 2026 Renewbuy’s $10M bridge round is more than just capital—it’s a vote of confidence in India’s evolving insurance distribution model. With the merger, the combined entity could pose a formidable challenge to incumbents and set the stage for India’s next insurtech giant. Stay updated with more such high-impact unlisted market stories on UnlistedZone.

A) Introduction

In a strategic move signaling deep consolidation in India’s insurtech space, Renewbuy has raised $10 million (₹86 crore) in fresh funding from existing investors Apis Partners and 360 One (formerly IIFL Wealth). This bridge round comes at a critical juncture as the company prepares to merge with rival InsuranceDekho, a merger that could reshape the competitive landscape in India's insurance broking sector.

B) Funding, Valuation & Merger Status
  • Amount Raised: $10 million (₹86 crore)

  • Investors: Apis Partners (UK), 360 One (IIFL Wealth)

  • Purpose: To support operations and expansion until the merger is finalized

  • Merger Partner: InsuranceDekho (CarDekho-backed)

  • First Reported: October 2024

  • IRDAI Approval: Pending

  • Valuation Estimate (Combined Entity): $1 billion

  • Renewbuy’s Last Valuation: $524 million (June 2023, per Tracxn)

C) Financials & Business Model
  • Revenue (FY24): ₹410 crore

  • Net Loss (FY24): ₹114 crore

  • Business Model: Hybrid distribution with physical agent network

  • Products: Motor, Health, and Life Insurance

  • Target Markets: Strong presence in Tier II and Tier III cities

D) Competition & Capital History
  • Competitors:

    • InsuranceDekho – CarDekho-backed, leading digital-first platform

    • PB Partners – Policybazaar's agent-led channel

    • Turtlemint – Backed by Peak XV (formerly Sequoia Capital)

  • Total Funds Raised: $41M+ since inception in 2014

  • Notable Backers: Apis Partners, 360 One, Dai-ichi Life (Japan)

E) Strategic Significance
  • Operational Continuity: The funding ensures that Renewbuy can continue scaling and servicing its network without disruptions while regulatory approvals are awaited.

  • Consolidation Trend: Signals a broader consolidation wave in Indian insurtech, as firms move from growth-at-all-costs to profitability and market share leadership.

  • Market Impact: The merged entity could emerge as India’s largest insurance broker, mounting serious competition for Policybazaar.

F) What This Means for Investors

For unlisted market investors, this deal highlights:

  • Renewed investor faith in hybrid distribution models

  • M&A potential as a value unlock mechanism

  • Attractive pre-IPO bets in India’s booming insurtech market

G) Final Outlook
  • IRDAI approval for the merger is expected in the coming quarters

  • Post-merger integration and potential IPO discussions may follow in 2026

  • Renewbuy’s $10M bridge round is more than just capital—it’s a vote of confidence in India’s evolving insurance distribution model. With the merger, the combined entity could pose a formidable challenge to incumbents and set the stage for India’s next insurtech giant.


Stay updated with more such high-impact unlisted market stories on UnlistedZone.

Disclaimer: This article is for informational purposes only and is not investment advice, nor an offer to buy or sell any security. Unlisted share prices are indicative. Please do your own research or consult a SEBI-registered advisor before investing.
Share this